|
UBE2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.49010000000061E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.82960000000487E-05 |
| Normal-vs-Stage2 |
1.933180E-01 |
| Normal-vs-Stage3 |
1.814800E-01 |
| Normal-vs-Stage4 |
9.143200E-01 |
| Stage1-vs-Stage2 |
2.913200E-01 |
| Stage1-vs-Stage3 |
1.244240E-01 |
| Stage1-vs-Stage4 |
5.431700E-02 |
| Stage2-vs-Stage3 |
8.215800E-01 |
| Stage2-vs-Stage4 |
3.382600E-01 |
| Stage3-vs-Stage4 |
3.602400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74920999999051E-05 |
| Normal-vs-AfricanAmerican |
5.968400E-02 |
| Normal-vs-Asian |
9.563000E-01 |
| Caucasian-vs-AfricanAmerican |
6.606000E-02 |
| Caucasian-vs-Asian |
1.787650E-01 |
| AfricanAmerican-vs-Asian |
5.280000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.61599999999318E-05 |
| Normal-vs-Female |
5.433600E-02 |
| Male-vs-Female |
3.546500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.100040E-02 |
| Normal-vs-Extreme_Weight |
8.19370000000319E-05 |
| Normal-vs-Obese |
4.019500E-03 |
| Normal-vs-Extreme_Obese |
4.830000E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.844200E-01 |
| Normal_Weight-vs-Obese |
8.844000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.120000E-01 |
| Extreme_Weight-vs-Obese |
4.146200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.814000E-01 |
| Obese-vs-Extreme_Obese |
5.068400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.702200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.143600E-03 |
| Normal-vs-Age(61-80Yrs) |
4.6494000000008E-06 |
| Normal-vs-Age(81-100Yrs) |
1.709160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.751000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.231050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.666000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.632100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.474600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.117600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.48749999998132E-06 |
| Normal-VS-Type2 PRCC |
3.780100E-02 |
| Normal-VS-KIRP CIMP |
3.903600E-02 |
| Normal-VS-Unclassified PRCC |
1.042380E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.372100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.631800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.893000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.492200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.236000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.367600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.404550E-03 |
| Normal-vs-N1 |
8.395600E-01 |
| Normal-vs-N2 |
1.383820E-01 |
| N0-vs-N1 |
3.676000E-02 |
| N0-vs-N2 |
8.152800E-01 |
| N1-vs-N2 |
4.328200E-01 |
|
|
